These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27109490)

  • 21. Antiangiogenic therapy and surgical practice.
    John AR; Bramhall SR; Eggo MC
    Br J Surg; 2008 Mar; 95(3):281-93. PubMed ID: 18278790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic antiangiogenic therapy: what goes around..
    Pulido JS; Itty S
    Br J Ophthalmol; 2009 Apr; 93(4):420-1. PubMed ID: 19321472
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dormant tumors and organs resistant to metastasis after gene transfer: dream and reality of anti-angiogenic gene therapy].
    Li H; Dkhissi F; Grenet C; Soria C; Lu H
    Therapie; 2001; 56(5):501-10. PubMed ID: 11806286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiangiogenic therapy at a crossroads: clinical trial results and future directions.
    Ellis LM
    J Clin Oncol; 2003 Dec; 21(23 Suppl):281s-283s. PubMed ID: 14645411
    [No Abstract]   [Full Text] [Related]  

  • 25. The interaction of radiation therapy and antiangiogenic therapy.
    O'Reilly MS
    Cancer J; 2008; 14(4):207-13. PubMed ID: 18677126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor as a target for antiangiogenic therapy.
    Gordon MS
    J Clin Oncol; 2000 Nov; 18(21 Suppl):45S-6S. PubMed ID: 11060326
    [No Abstract]   [Full Text] [Related]  

  • 27. The Contribution of Angiogenesis to the Process of Metastasis.
    Bielenberg DR; Zetter BR
    Cancer J; 2015; 21(4):267-73. PubMed ID: 26222078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999).
    d'Onofrio A; Gandolfi A
    Math Biosci; 2004 Oct; 191(2):159-84. PubMed ID: 15363652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The new cancer blockers.
    Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):1-2, 7. PubMed ID: 15602777
    [No Abstract]   [Full Text] [Related]  

  • 30. [Angiogenesis as part of the tumor "ecosystem" and possibilities to influence it].
    Klener P
    Klin Onkol; 2010; 23(1):14-20. PubMed ID: 20192069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenesis as a therapeutic target.
    Ferrara N; Kerbel RS
    Nature; 2005 Dec; 438(7070):967-74. PubMed ID: 16355214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiangiogenesis: the fifth cancer treatment modality?
    Camp-Sorrell D
    Oncol Nurs Forum; 2003; 30(6):934-44. PubMed ID: 14603351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antivascular cancer treatments: imaging biomarkers in pharmaceutical drug development.
    Galbraith SM
    Br J Radiol; 2003; 76 Spec No 1():S83-6. PubMed ID: 15456717
    [No Abstract]   [Full Text] [Related]  

  • 34. Closing in on cancer.
    Park A
    Time; 2001 May; 157(20):60, 62. PubMed ID: 11383110
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.
    Hlatky L; Hahnfeldt P; Folkman J
    J Natl Cancer Inst; 2002 Jun; 94(12):883-93. PubMed ID: 12072542
    [No Abstract]   [Full Text] [Related]  

  • 36. An hematotherapist's point of view. Congratulations to angiogenesis research.
    Ribatti D
    J Hematother Stem Cell Res; 2001 Dec; 10(6):917-8. PubMed ID: 11798519
    [No Abstract]   [Full Text] [Related]  

  • 37. Rationale, problems and perspectives in anti-angiogenic therapy.
    Lorusso G; Dell'Eva R; Vené R; Pfeffer U; Albini A
    Tumori; 2001; 87(6):S17-9. PubMed ID: 11989611
    [No Abstract]   [Full Text] [Related]  

  • 38. Cancer researchers target angiogenesis.
    Hampton T
    JAMA; 2003 Nov; 290(19):2529-33. PubMed ID: 14625314
    [No Abstract]   [Full Text] [Related]  

  • 39. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
    Roukos DH; Tzakos A; Zografos G
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeting angiogenic metabolism in disease.
    Li X; Carmeliet P
    Science; 2018 Mar; 359(6382):1335-1336. PubMed ID: 29567696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.